Ensign Peak Advisors, Inc Anika Therapeutics, Inc. Transaction History

Ensign Peak Advisors, Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$25.16 - $28.86 $35,224 - $40,404	1,400 Added 9.4%	16,300 $423,000
Q1 2023 May 15, 2023	BUY	$25.91 - $32.1 $108,822 - $134,820	4,200 Added 39.25%	14,900 $427,000
Q4 2022 Feb 13, 2023	BUY	$23.85 - $31.91 $109,710 - $146,786	4,600 Added 75.41%	10,700 $316,000
Q4 2021 Feb 11, 2022	SELL	$35.83 - $45.03 $347,551 - $436,791	-9,700 Reduced 61.39%	6,100 $219,000
Q4 2020 Feb 12, 2021	SELL	$32.59 - $45.26 $6,518 - $9,052	-200 Reduced 1.25%	15,800 $715,000
Q4 2019 Feb 14, 2020	BUY	$51.85 - $73.36 $829,600 - $1.17 Million	16,000 New	16,000 $830,000

124

11.4M

200

100

Ticker ANIK
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,599,900
Market Cap $260M
Description
Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ensign Peak Advisors, Inc with notifications on news.